Volume 53, Issue 6 pp. 1010-1017

Multiplex polymerase chain reaction for six herpesviruses after hematopoietic stem cell transplantation

Akihisa Sawada

Corresponding Author

Akihisa Sawada

Department of Hematology/Oncology

Akihisa Sawada, MD, PhD, Department of Hematology/Oncology, Osaka Medical Center and Research Institute for Maternal and Child Health, 840 Murodo, Izumi City, Osaka 594-1101, Japan. Email: [email protected]Search for more papers by this author
Maho Koyama-Sato

Maho Koyama-Sato

Department of Hematology/Oncology

Search for more papers by this author
Masahiro Yasui

Masahiro Yasui

Department of Hematology/Oncology

Search for more papers by this author
Osamu Kondo

Osamu Kondo

Department of Hematology/Oncology

Search for more papers by this author
Takashi Ishihara

Takashi Ishihara

Department of Hematology/Oncology

Search for more papers by this author
Yasufumi Takeshita

Yasufumi Takeshita

Department of Hematology/Oncology

Search for more papers by this author
Takayuki Okamura

Takayuki Okamura

Department of Hematology/Oncology

Search for more papers by this author
Masanori Nishikawa

Masanori Nishikawa

Department of Radiology, Osaka Medical Center and Research Institute for Maternal and Child Health, Osaka, Japan

Search for more papers by this author
Masami Inoue

Masami Inoue

Department of Hematology/Oncology

Search for more papers by this author
Keisei Kawa

Keisei Kawa

Department of Hematology/Oncology

Search for more papers by this author
First published: 02 August 2011
Citations: 8

Abstract

Background: Herpesviruses cause life-threatening diseases after hematopoietic stem cell transplantation (HSCT). It is necessary that viral diseases are identified early and safely diagnosed. The purpose of this study was to evaluate the efficacy of multiplex polymerase chain reaction (PCR) for qualitative detection of the six herpesviruses simultaneously: herpes simplex virus type 1 and type 2, varicella-zoster virus, cytomegalovirus, Epstein–Barr virus (EBV) and human herpesvirus 6B.

Methods: Multiplex PCR was applied to patients with various clinical manifestations including central nervous system, cutaneous and mucosal complications after allogeneic HSCT, and the data were retrospectively analyzed.

Results: Patients positive for cytomegalovirus in peripheral blood by multiplex PCR might need pre-emptive treatment, but a positive result for EBV had no specific correlation with EBV-associated post-transplant lymphoproliferative disease, and positive result for human herpesvirus 6B failed to show any clinical significance. The multiplex PCR was safe and helpful to diagnose viral diseases of local regions, for example, the central nervous system, skin and mucosa.

Conclusions: It may be worthwhile to survey the six herpesviruses with multiplex PCR after HSCT.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.